Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Gynecologic Oncology|March 30, 1999
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancerA Husain, P Sabbatini, D Spriggs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.Gynecologic Oncology|July 1, 1993
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapyM Markman, W Jones, J L Lewis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancerM Markman, B Reichman, T Hakes, et al.Seminars in Oncology|December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?M Markman, T Hakes, B Reichman, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapyM Markman, B Reichman, T Hakes, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancerM Markman, T Hakes, B Reichman, et al.Pageof 9